Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antihypertensive Effects of a Fixed-dose Combination of Losartan and Hydrochlorothiazide Plus Amlodipine Versus a Hydrochlorothiazide and Atenolol Combination Plus Amlodipine in Subjects With Ambulatory Systolic Hypertension.

NCT00140959 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00140959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00140959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antihypertensive Effects of a Fixed-dose Combination of Losartan and Hydrochlorothiazide Plus Amlodipine Versus a Hydrochlorothiazide and Atenolol Combination Plus Amlodipine in Subjects With Ambulatory Systolic Hypertension.
Lead sponsor
Organon and Co
Phase
Phase 4
Overall status
Completed
Start date
February 1, 2003
Completion date
June 30, 2004
Enrollment
120
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension